• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Model Number 1804250-15
Medical Device Problem Codes Material Rupture (1546); Improper or Incorrect Procedure or Method (2017); Difficult to Advance (2920); Material Deformation (2976)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 08/01/2022
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
(b)(4).The device will not be returned for evaluation, the device was reportedly discarded.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event or Problem Description
It was reported that prior to use of the 2.50x15mm xience skypoint stent delivery system (sds) the protective sheath was removed without resistance.The catheter was soaked in saline and the device was prepped (air aspiration) inside the anatomy.The procedure was to treat a 90% stenosed lesion in the distal left circumflex artery with heavy calcification and heavy tortuosity.The sds was advanced to the target lesion with difficulty due to the anatomy.However, the balloon burst during the first inflation after 20 seconds at 12 atmospheres (atm).The sds was removed from the patient.There was no adverse patient effect and no clinically significant delay reported in the procedure.No additional information has been provided.
 
Additional Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.It was reported xience sypoint stent delivery system (sds) was prepped inside the anatomy.It should be noted that the xience skypoint everolimus eluting coronary stent system instruction for use (ifu) lists delivery system preparation to be performed prior to delivery procedure.In this case, it is unknown if the instruction for use (ifu) deviation related to incorrect stent preparation may have contributed to the reported event.The investigation determined the reported difficulty to advance and material deformation appear to be related to circumstances of the procedure.The investigation was unable to determine a conclusive cause for the reported material rupture.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Event or Problem Description
Subsequent to initial report, the following information was reported: it was reported that the stent edge may have become flared.No additional information has been provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Common Device Name
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key15459785
Report Number2024168-2022-09908
Device Sequence Number5569864
Product Code NIQ
UDI-Device Identifier08717648233074
UDI-Public08717648233074
Combination Product (Y/N)Y
Initial Reporter CountryJA
PMA/510(K) Number
P110019
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 11/14/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/15/2024
Device Model Number1804250-15
Device Catalogue Number1804250-15
Device Lot Number1031041
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 08/31/2022
Supplement Date Received by Manufacturer11/08/2022
Initial Report FDA Received Date09/20/2022
Supplement Report FDA Received Date11/14/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured03/16/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-